Amneal Pharmaceuticals, Inc. Class A Common Stock
$13.83
Market Capitalization:
$4.35B
Amneal Pharmaceuticals Class A Price Chart
Amneal Pharmaceuticals Class A Price Chart
5:40 AM
7:00 AM
8:20 AM
9:40 AM
11:00 AM
12:20 PM
1:40 PM 14.95 14.76 14.57 14.38 14.18 13.99 13.80
Amneal Pharmaceuticals Class A Volume Chart
Amneal Pharmaceuticals Class A Volume Chart
5:40 AM 7:00 AM 8:20 AM 9:40 AM 11:00 AM 12:20 PM 1:40 PM
54.10K 46.37K 38.64K 30.91K 23.18K 15.46K 7.73K
Amneal Pharmaceuticals Class A Market Segments
Regular Trading Hours -0.40(-2.81%)
Open $14.23 Close $13.83 Low $13.80 Low Change -0.44 (-3.06%) High $14.67 High Change +0.44 (+3.06%) Range $0.87 Volume 1.512M Dollar Volume $20.92M
Premarket -0.01(-0.07%)
Open $14.59 Close $14.58 Low $14.39 Low Change -0.20 (-1.37%) High $14.95 High Change +0.36 (+2.47%) Range $0.56 Volume 14.663K Dollar Volume $213.79K
After Hours Yesterday +0.21(+1.45%)
Open $14.49 Close $14.70 Low $14.49 Low Change 0.00 (0.00%) High $14.85 High Change +0.36 (+2.48%) Range $0.36 Volume 38.386K Dollar Volume $564.27K
Regular Trading Hours Yesterday -0.09(-0.58%)
Open $14.58 Close $14.50 Low $14.31 Low Change -0.28 (-1.89%) High $14.66 High Change +0.08 (+0.55%) Range $0.36 Volume 1.274M Dollar Volume $18.47M
Premarket Yesterday +0.06(+0.41%)
Open $14.69 Close $14.75 Low $14.69 Low Change 0.00 (0.00%) High $14.85 High Change +0.16 (+1.09%) Range $0.16 Volume 340 Dollar Volume $5.02K
Amneal Pharmaceuticals Class A Statistics
Average Volume (30 Days) 3.15M
P/E Ratio (Current) 729.00
EPS (Current) $0.02
Dividend Yield 0.85%
Free Cash Flow $255.89M
Cash Ratio 0.23
Current Ratio 2.09
Quick Ratio 1.38
Debt to Equity -23.51
Enterprise Value $6.96B
EV to EBITDA 11.56
EV to Sales 2.37
Price to Book -41.87
Price to Cash Flow 13.98
Price to Free Cash Flow 17.91
Price to Sales 1.56
Return on Assets 0.00%
Return on Equity -0.05%
Amneal Pharmaceuticals Class A Stock Splits
There has been 1 stock split for Amneal Pharmaceuticals Class A (AMRX). The reverse stock split occured on August 26, 2013 and reduced the outstanding shares at a ratio of 25:1.
Date Type Ratio August 26, 2013 Reverse 25:1